Gain Therapeutics
Earnings Surprise
Analysts estimated GANX earnings of $-0.15 per share this quarter (Q4). GANX's actual earnings were $-0.11 per share.
GANX EPS surprise of 25.63%Analysts estimated GANX earnings of $-0.17 per share this quarter (Q2). GANX's actual earnings were $-0.19 per share.
GANX EPS surprise of -10.66%Analysts estimated GANX earnings of $-0.18 per share this quarter (Q1). GANX's actual earnings were $-0.16 per share.
GANX EPS surprise of 12.85%Analysts estimated GANX earnings of $-0.19 per share this quarter (Q4). GANX's actual earnings were $-0.11 per share.
GANX EPS surprise of 41.18%Analysts estimated GANX earnings of $-0.22 per share this quarter (Q3). GANX's actual earnings were $-0.17 per share.
GANX EPS surprise of 22.48%Analysts estimated GANX earnings of $-0.20 per share this quarter (Q2). GANX's actual earnings were $-0.42 per share.
GANX EPS surprise of -105.88%Analysts estimated GANX earnings of $-0.30 per share this quarter (Q1). GANX's actual earnings were $-0.22 per share.
GANX EPS surprise of 26.27%Analysts estimated GANX earnings of $-0.33 per share this quarter (Q4). GANX's actual earnings were $-0.36 per share.
GANX EPS surprise of 9.42%Analysts estimated GANX earnings of $-0.45 per share this quarter (Q3). GANX's actual earnings were $-0.37 per share.
GANX EPS surprise of -18.66%